Remove production automation-control
article thumbnail

QA/QC & Microbiology In-Depth Focus 2023

European Pharmaceutical Review

She discusses rapid sterility testing methods, regulatory frameworks, and the impact of automation and digitalisation on microbiological quality control. The post QA/QC & Microbiology In-Depth Focus 2023 appeared first on European Pharmaceutical Review.

92
article thumbnail

Control strategy could facilitate faster bioburden detection

European Pharmaceutical Review

Biopharma and bioprocessing experts have proposed an approach that uses a two-tiered control strategy for rapid bioburden testing, that can beneficially, “leverage faster detection times”. Specifically, the first assay is “suited for continuous in-process demonstration of the validated state”.

92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Trends & Requirements from Digitalization, Annex 1, Continuous Manufacturing & High Potent Manufacturing

ISPE

The major trends in the recent years are (1) fully automated production such as continuous manufacturing and (2) the adoption of digitalized processes for paperless production. One of the key changes in the latest revision of Annex 1 is a focus on Contamination Control Strategy (CCS) and Quality Risk Management (QRM).

article thumbnail

The role of GAMP 5, data integrity and QbD in pharmaceutical quality assurance

European Pharmaceutical Review

The authors explained first that “a robust quality assurance framework” is needed to ensure medicinal products are safe and efficient. defined GAMP as ‘good automated manufacturing practices’, with GAMP 5 being “a widely used framework for validating automated systems that establishes quality assurance practices. Pedro et al.

83
article thumbnail

European Pharmaceutical Review Issue 5 2023

European Pharmaceutical Review

Issue 5 of European Pharmaceutical Review features articles on manufacturing, development and quality control of biopharmaceuticals from antibodies to mRNA and cell and gene therapies. When it comes to biologics, scaling up production to ensure global supply is a remarkable process that embodies Industry 4.0

81
article thumbnail

Biologics driving continuous bioprocessing market expansion

European Pharmaceutical Review

The research explained that companies are looking to reduce manufacturing costs and increase productivity, which is driving implementation of this type of bioprocessing. Market drivers However, technology innovations such as automation, sensor technology, and process control systems are driving adoption of continuous bioprocessing.

article thumbnail

Achieving optimal advanced process control in bioproduction

European Pharmaceutical Review

According to a paper published in Bioprocess Control , as an advanced process control method, Model Predictive Control (MPC) can optimise biomanufacturing operations and ensure consistent product yields. However, MPC can significantly enhance the effectiveness of continuous biomanufacturing. Eslami et al.

74